Article Details
Retrieved on: 2022-05-12 12:25:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
TheStreet lowered shares of Vir Biotechnology from a “c-” rating to a “d+” rating in a research note on Monday, March 28th. Needham & Company LLC ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here